Status:
COMPLETED
Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Diphtheria
Tetanus
Eligibility:
All Genders
6-8 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the safety, tolerability, and immune response of an investigational vaccine being evaluated to reduce the incidence of diphtheria, pertussis, tetanus, hepatiti...
Detailed Description
The duration of treatment is 65 weeks.
Eligibility Criteria
Inclusion
- Healthy infant who received Hepatitis B vaccine within 5 days of birth and whose mother is negative to Hepatitis B surface antigen
Exclusion
- Problems with immune system
- Recent illness with fever
Key Trial Info
Start Date :
March 1 2002
Trial Type :
INTERVENTIONAL
End Date :
August 1 2003
Estimated Enrollment :
151 Patients enrolled
Trial Details
Trial ID
NCT00092469
Start Date
March 1 2002
End Date
August 1 2003
Last Update
October 7 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.